Skip to Content
You are currently on the new version of our website. Access the old version .
  • Feature Paper
  • Article
  • Open Access

11 May 2021

19 Pages

Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital

,
,
,
,
,
,
,
,
…
1
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA
2
Arkansas Children’s Research Institute, Little Rock, AR 72202, USA
3
Pediatrics and Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA
4
Departments of Pathology and Laboratory Medicine, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Little Rock, AR 72202, USA

Abstract

Pharmacogenomics (PGx) is a growing field within precision medicine. Testing can help predict adverse events and sub-therapeutic response risks of certain medications. To date, the US FDA lists over 280 drugs which provide biomarker-based dosing guidance for adults and children. At Arkansas Children’s Hospital (ACH), a clinical PGx laboratory-based test was developed and implemented to provide guidance on 66 pediatric medications for genotype-guided dosing. This PGx test consists of 174 single nucleotide polymorphisms (SNPs) targeting 23 clinically actionable PGx genes or gene variants. Individual genotypes are processed to provide per-gene discrete results in star-allele and phenotype format. These results are then integrated into EPIC- EHR. Genomic indicators built into EPIC-EHR provide the source for clinical decision support (CDS) for clinicians, providing genotype-guided dosing.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.